Business Description
StemRIM Inc
ISIN : JP3399690001
Description
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.98 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -52.1 | |||||
| 3-Year EPS without NRI Growth Rate | -49.4 | |||||
| 3-Year FCF Growth Rate | -43.2 | |||||
| 3-Year Book Growth Rate | -7.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.05 | |||||
| 9-Day RSI | 33.5 | |||||
| 14-Day RSI | 36.59 | |||||
| 3-1 Month Momentum % | -11.57 | |||||
| 6-1 Month Momentum % | -10.92 | |||||
| 12-1 Month Momentum % | -36.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 131.47 | |||||
| Quick Ratio | 131.03 | |||||
| Cash Ratio | 124.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -20.87 | |||||
| ROA % | -20.36 | |||||
| ROIC % | -351.74 | |||||
| 3-Year ROIIC % | 2775.77 | |||||
| ROC (Joel Greenblatt) % | -391.42 | |||||
| ROCE % | -20.59 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.16 | |||||
| Price-to-Tangible-Book | 2.24 | |||||
| EV-to-EBIT | -5.78 | |||||
| EV-to-EBITDA | -5.78 | |||||
| EV-to-FCF | -6.57 | |||||
| Price-to-GF-Value | 0.36 | |||||
| Price-to-Projected-FCF | 7.92 | |||||
| Price-to-Net-Current-Asset-Value | 2.29 | |||||
| Price-to-Net-Cash | 2.42 | |||||
| Earnings Yield (Greenblatt) % | -17.29 | |||||
| FCF Yield % | -9.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
StemRIM Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -32.98 | ||
| Beta | 1.14 | ||
| 3-Year Sharpe Ratio | 0.02 | ||
| 3-Year Sortino Ratio | 0.04 | ||
| Volatility % | 27.42 | ||
| 14-Day RSI | 36.59 | ||
| 14-Day ATR (円) | 12.804527 | ||
| 20-Day SMA (円) | 349.65 | ||
| 12-1 Month Momentum % | -36.51 | ||
| 52-Week Range (円) | 321 - 620 | ||
| Shares Outstanding (Mil) | 61.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
StemRIM Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
StemRIM Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
StemRIM Inc Frequently Asked Questions
What is StemRIM Inc(TSE:4599)'s stock price today?
The current price of TSE:4599 is 円324.00. The 52 week high of TSE:4599 is 円620.00 and 52 week low is 円321.00.
When is next earnings date of StemRIM Inc(TSE:4599)?
The next earnings date of StemRIM Inc(TSE:4599) is .
Does StemRIM Inc(TSE:4599) pay dividends? If so, how much?
StemRIM Inc(TSE:4599) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers